NCT02279498 - SOLUTION: Study of Oral Liprotamase Unit-Matched Therapy Of Non-Porcine Origin in Patients With Cystic Fibrosis | Biotech Hunter

Enrollment

128

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

October 31, 2016

Study Completion Date

January 20, 2017

Conditions

Exocrine Pancreatic InsufficiencyCystic Fibrosis

Interventions

DRUG

Liprotamase

oral, soluble, non-enterically coated, non-porcine, pancreatic enzyme replacement

DRUG

porcine (pig) PERT

oral, enterically-coated, pancreatic replacement enzymes prepared from a porcine source

Trial Locations (54)

2045

Investigator Site 302, Törökbálint

4031

Investigator Site 303, Debrecen

6720

Investigator Site 305, Szeged

7257

Investigator Site 304, Mosdós

8400

Investigator Site 301, Ajka

15224

Investigator Site 115, Pittsburgh

17033

Investigator Site 106, Hershey

23219

Investigator Site 112, Richmond

26506

Investigator Site 129, Morgantown

28006

Investigator Site 403, Madrid

28046

Investigator Site 401, Madrid

29009

Investigator Site 402, Málaga

30342

Investigator Site 110, Atlanta

32207

Investigator Site 102, Jacksonville

32610

Investigator Site 120, Gainesville

32803

Investigator Site 117, Orlando

33136

Investigator Site 130, Miami

39216

Investigator Site 134, Jackson

40202

Investigator Site 122, Louisville

40506

Investigator Site 128, Lexington

43606

Investigator Site 113, Toledo

44106

Investigator Site 103, Cleveland

46026

Investigator Site 404, Valencia

46202

Investigator Site 104, Indianapolis

48823

Investigator Site 126, East Lansing

60025

Investigator Site 109, Glenview

60611

Investigator Site 127, Chicago

62500

Investigator Site 501, Brno

67214

Investigator Site 105, Wichita

73104

Investigator Site 101, Oklahoma City

73112

Investigator Site 136, Oklahoma City

75390

Investigator Site 111, Dallas

76104

Investigator Site 125, Fort Worth

77030

Investigator Site 116, Houston

80045

Investigator Site 114, Aurora

89107

Investigator Site 135, Las Vegas

90033

Investigator Site 107, Los Angeles

90806

Investigator Site 123, Long Beach

97239

Investigator Site 119, Portland

9124001

Investigator Site 601, Jerusalem

04102

Investigator Site 132, Portland

48109-5212

Investigator Site 124, Ann Arbor

05405

Investigator Site 121, Burlington

T6G IC9

Investigator Site 133, Edmonton

305 99

Investigator Site 502, Pilsen

15-044

Investigator Site 208, Bialystok

58-540

Investigator Site 203, Karpacz

90-329

Investigator Site 206, Lodz

20-093

Investigator Site 201, Lublin

20-362

Investigator Site 205, Lublin

34-700

Investigator Site 202, Rabka-Zdrój

35-312

Investigator Site 209, Rzeszów

81-713

Investigator Site 204, Sopot

01-195

Investigator Site 207, Warsaw